Table 6.
Age | Host status | Etiology | Site | Anatomic nature | Risk factors | Management strategy | Treatment |
---|---|---|---|---|---|---|---|
44 | B | Contiguous post-traumatic | Tibia | IV | Compliance and motivation | Curative | Wide resection, Masquelet bone transport |
34 | C | Contiguous post-traumatic | Ankle | IV | HIV infection (CD4 <350 cells/mm3), smoking, joint involved | Alternative | Patient refused amputation, marginal debridement and acute shortening |
25 | C | Contiguous post-traumatic | Tibia | IV | HIV infection (CD4 <350 cells/mm3) | Alternative | Circular fixation, fibula osteotomy, CSATa |
30 | C | Contiguous post-traumatic | Midfoot | IV | Poor soft tissue, joint involved, foot, local extent | Palliative | CSATa |
49 | C | Contiguous post-traumatic | Tibia | III | HIV infection (CD4 <350 cells/mm3), poor soft tissue, local extent, debridement will result in instability | Palliative | CSATa |
26 | B | Contiguous post-traumatic | Proximal tibia | IV | Failed reconstruction elsewhere, joint involved, poor soft tissues | Curative | Wide resection, classic Masquelet |
45 | C | Contiguous post-operative | Proximal femur | III | Chronic venous insufficiency, joint involved, local extent, debridement will result in instability | Palliative | CSATa |
65 | C | Contiguous post-operative | Femur | III | Ischemic heart disease, smoker, diabetes mellitus (HbA1c > 8), age | Palliative | CSATa |
46 | B | Hematogenous | Pelvis | III | Smoking, local extent, pelvis | Curative | Marginal resection, PMMA beads |
38 | C | Contiguous post-operative | Humerus | IV | HIV infection (CD4<350cells/mm3), adjacent joint stiffness, local extent, diabetes mellitus | Palliative | CSATa |
48 | C | Contiguous post-traumatic | Proximal tibia | III | HIV infection (CD4 <350 cells/mm3), smoking, local extent, poor soft tissues | Palliative | CSATa |
Chronic suppressive antibiotic therapy.